TFOS DEWS II Introduction

J. Daniel Nelson; Jennifer P. Craig; Esen K. Akpek; Dimitri T. Azar; Carlos Belmonte; Anthony J. Bron; Janine A. Clayton; Murat Dogru; Harminder S. Dua; Gary N. Foulks; José A.P. Gomes; Katherine M. Hammitt; Juha Holopainen; Lyndon Jones; Choun Ki Joo; Zuguo Liu; Jason J. Nichols; Kelly K. Nichols; Gary D. Novack; Virender Sangwan; Fiona Stapleton; Alan Tomlinson; Kazuo Tsubota; Mark D.P. Willcox; James S. Wolffsohn; David A. Sullivan

doi:10.1016/j.jtos.2017.05.005

TFOS DEWS II Introduction

J. Daniel Nelson, Jennifer P. Craig, Esen K. Akpek, Dimitri T. Azar, Carlos Belmonte, Anthony J. Bron, Janine A. Clayton, Murat Dogru, Harminder S. Dua, Gary N. Foulks, José A.P. Gomes, Katherine M. Hammitt, Juha Holopainen, Lyndon Jones, Choun Ki Joo, Zuguo Liu, Jason J. Nichols, Kelly K. Nichols, Gary D. Novack, Virender SangwanFiona Stapleton, Alan Tomlinson, Kazuo Tsubota, Mark D.P. Willcox, James S. Wolffsohn, David A. Sullivan

Department of Ophthalmology

Research output: Contribution to journal › Review article › peer-review

78 Citations (Scopus)

Original language	English
Pages (from-to)	269-275
Number of pages	7
Journal	Ocular Surface
Volume	15
Issue number	3
DOIs	https://doi.org/10.1016/j.jtos.2017.05.005
Publication status	Published - 2017 Jul

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.jtos.2017.05.005

Cite this

Nelson, J. D., Craig, J. P., Akpek, E. K., Azar, D. T., Belmonte, C., Bron, A. J., Clayton, J. A., Dogru, M., Dua, H. S., Foulks, G. N., Gomes, J. A. P., Hammitt, K. M., Holopainen, J., Jones, L., Joo, C. K., Liu, Z., Nichols, J. J., Nichols, K. K., Novack, G. D., ... Sullivan, D. A. (2017). TFOS DEWS II Introduction. Ocular Surface, 15(3), 269-275. https://doi.org/10.1016/j.jtos.2017.05.005

TFOS DEWS II Introduction. / Nelson, J. Daniel; Craig, Jennifer P.; Akpek, Esen K.; Azar, Dimitri T.; Belmonte, Carlos; Bron, Anthony J.; Clayton, Janine A.; Dogru, Murat; Dua, Harminder S.; Foulks, Gary N.; Gomes, José A.P.; Hammitt, Katherine M.; Holopainen, Juha; Jones, Lyndon; Joo, Choun Ki; Liu, Zuguo; Nichols, Jason J.; Nichols, Kelly K.; Novack, Gary D.; Sangwan, Virender; Stapleton, Fiona; Tomlinson, Alan; Tsubota, Kazuo; Willcox, Mark D.P.; Wolffsohn, James S.; Sullivan, David A.

In: Ocular Surface, Vol. 15, No. 3, 07.2017, p. 269-275.

Research output: Contribution to journal › Review article › peer-review

Nelson, JD, Craig, JP, Akpek, EK, Azar, DT, Belmonte, C, Bron, AJ, Clayton, JA, Dogru, M, Dua, HS, Foulks, GN, Gomes, JAP, Hammitt, KM, Holopainen, J, Jones, L, Joo, CK, Liu, Z, Nichols, JJ, Nichols, KK, Novack, GD, Sangwan, V, Stapleton, F, Tomlinson, A, Tsubota, K, Willcox, MDP, Wolffsohn, JS & Sullivan, DA 2017, 'TFOS DEWS II Introduction', Ocular Surface, vol. 15, no. 3, pp. 269-275. https://doi.org/10.1016/j.jtos.2017.05.005

Nelson, J. Daniel ; Craig, Jennifer P. ; Akpek, Esen K. ; Azar, Dimitri T. ; Belmonte, Carlos ; Bron, Anthony J. ; Clayton, Janine A. ; Dogru, Murat ; Dua, Harminder S. ; Foulks, Gary N. ; Gomes, José A.P. ; Hammitt, Katherine M. ; Holopainen, Juha ; Jones, Lyndon ; Joo, Choun Ki ; Liu, Zuguo ; Nichols, Jason J. ; Nichols, Kelly K. ; Novack, Gary D. ; Sangwan, Virender ; Stapleton, Fiona ; Tomlinson, Alan ; Tsubota, Kazuo ; Willcox, Mark D.P. ; Wolffsohn, James S. ; Sullivan, David A. / TFOS DEWS II Introduction. In: Ocular Surface. 2017 ; Vol. 15, No. 3. pp. 269-275.

@article{4f8c4803055245f59b7ea7eb65fe0713,

title = "TFOS DEWS II Introduction",

author = "Nelson, {J. Daniel} and Craig, {Jennifer P.} and Akpek, {Esen K.} and Azar, {Dimitri T.} and Carlos Belmonte and Bron, {Anthony J.} and Clayton, {Janine A.} and Murat Dogru and Dua, {Harminder S.} and Foulks, {Gary N.} and Gomes, {Jos{\'e} A.P.} and Hammitt, {Katherine M.} and Juha Holopainen and Lyndon Jones and Joo, {Choun Ki} and Zuguo Liu and Nichols, {Jason J.} and Nichols, {Kelly K.} and Novack, {Gary D.} and Virender Sangwan and Fiona Stapleton and Alan Tomlinson and Kazuo Tsubota and Willcox, {Mark D.P.} and Wolffsohn, {James S.} and Sullivan, {David A.}",

note = "Funding Information: J. D. Nelson, Chair: TearSolutions (I, C, R), Santen (F, C), Editor in Chief, Ocular Surface (F). J. P. Craig, Vice Chair: Allergan (Oculeve), Manuka Health NZ (F), E-Swin, CooperVision, Alcon, Optima Pharmaceuticals, OPSM NZ, Akorn, Optimed, Medmont (R); Carl Zeiss Meditec, Eye Institute Auckland (C). D. A. Sullivan, Organizer: Allergan, Cempra, GlaxoSmithKline, Novagali/Santen, TearLab, (F); Singularis (I); M.G. Therapeutics (C); Domp{\'e}, Fovea, Laboratoire Th{\'e}a, Lμbris Sanofi/Novartis, (R). E. Akpek: Allergan (F); Biogen, Seattle Genetics, GSK, Nicox (C). D. Azar: Novartis/Alcon, Google. Chicago Medical Society (F); Novartis, Google, (I); University of Illinois (E); Alcon/Google (C); Novartis/Alcon/Google (R). C. Belmonte: Avizorex Pharma, (F) (I) (C) (P) (R); Coopervision (F). A. J. Bron: Allergan, DiagnosTear, TearLab, Reckitt Benckiser (C); Allergan (R); TearLab (F) (I). J. A. Clayton: National Institutes of Health (E). M. Dogru: Otsuka Pharmaceuticals (F), Santen (F). H. Dua: Novartis (F); GlaxoSmithKline (I); Nicox, Th{\'e}a, Allergan (C); NuVision (P); Alcon, Allergan, Bausch & Lomb, Nicox, Th{\'e}a; NuVision (S). G. N. Foulks: TearLab (I); Eleven Biotherapeutics, Inc; Healios, Inc; Insite Pharmaceuticals, Inc; Kala, Inc; Lexitas, Inc; Parion, Inc; R-Tech Ueno, Inc; and Shire Pharmaceuticals, Inc. (C). J. A. P. Gomes: Allergan, Alcon, Bausch & Lomb/Valeant, Genon, Pfizer, MSD, Mundipharma (F); Allergan, Bausch & Lomb/Valeant (C). K. M. Hammitt: N. L. Jones: Advanced Vision Research, Alcon, Allergan, Contamac, CooperVision, Essilor, Inflamax, Johnson & Johnson Vision Care, Ocular Dynamics, Oculus, Safilens, TearLab, TearScience (F); Alcon, CooperVision, Johnson & Johnson Vision Care (C) (R). C-K. Joo: N. Z. Liu: Reilin Co. (C); Santen, Reilin, Alcon (R). J. J. Nichols: Johnson and Johnson Vision Care (F); Bruder Healthcare Company (F); Alcon (spouse), Allergan (spouse), Eleven Biotherapeutics (spouse), Kala, Oculus (spouse), Sarcode/Shire (spouse), TearScience (spouse), (F); Alcon (Spouse), Allergan (Spouse), Bausch & Lomb/Valeant (spouse), Eleven Biotherapeutics (spouse), Kala (Spouse), Insite Pharma (spouse), Parion (spouse), Sarcode/Shire (spouse), ScienceBased Health (spouse), Santen (spouse), Tearfilm Innovations (spouse), (C); Shire (R). K. K. Nichols: Allergan, Bruder Healthcare Company (spouse) Eleven Biotherapeutics, Johnson and Johnson Vision Care (spouse), Kala, Oculus, Sarcode/Shire, TearScience (F); Alcon, Allergan, Bausch & Lomb/Valeant, Eleven Biotherapeutics, Kala, Insite Pharma, Parion, Sarcode/Shire, ScienceBased Health, Santen, Tearfilm Innovations (C); Shire (Spouse) (R). G. D. Novack: Aldeyra, Allergan, Allysta, AmorChem, Aurinia Pharm, Auven, Bausch+ Lomb, CapaBio, Clementia Pharma, Eleven Biotherapeutics, I.com Medical, Kala Pharma, Lexitas Pharma, Lubris, MG Therapeutics, Oculeve, Oyster Point Pharma, Panoptica, Inc., Parion Sciences, Inc., Proteris Biotech, Inc., Senju Pharmaceutical Co., Ltd, Shire Pharmaceuticals, Inc., Sun Pharma, Sylentis, Theravance (C). V. Sangwan: N. F. Stapleton: Alcon Laboratories, Allergan, CooperVision, Johnson & Johnson Vision Care, Stiltec (F); Nidek (C). K. Tsubota: Dai Nippon Insatsu, Echo Denki, JIN Co, Ltd., Kowa Co. Ltd., MediProduct, Inc., Molecular Physiology Chemistry Laboratory, Inc., Novartis Pharma K.K., Oryza Oil & Fat Chemical Co., Ltd., Santen Pharmaceutical Co., Ltd., Toshiba Materials Co., Ltd., WAKASA SEIKATSU Corp. (F); QOV, Inc., Tear Solutions, Tissue Tech Inc., Tsubota Laboratory, Inc. (I); Laboratoires Th{\'e}a, Novaliq GmbH, SIFI, SpA (C); Functional Visual Acuity Meter, Moisture Glasses, Menisometry Strips, Vitamin D Ointment (P); AMO Japan K.K.; NIDEK Co. Ltd., Otsuka Pharmaceutical Co Ltd; Santen Pharmaceutical Co., Ltd. (R); Ocular Surface Research & Education Foundation (Board of Directors); Qualitas Inc., (Advisory Board); TearSolutions (Advisory Board); Yolia Health (Advisory Board); Metro Biotech (Advisory Board); Nobel Institute of Medical Science; (Spouse's company) (S). M. D. P. Willcox: Alcon Laboratories, Allergan, CooperVision, Johnson & Johnson Vision Care, Ophtecs (F); Allergan, Minomic International Pty., Ophtecs, Warm Contacts (C); Allergan, Ophtecs (R); Minomic International Pty., Ophtecs (S). J. S. Wolffsohn: Alcon, Bausch + Lomb, CooperVision, Eaglet Eye, European Union, Eyebag, EMPharma, EyeDocs, Innovate UK, Johnson & Johnson, Medmont, Th{\'e}a, Optimec, Visioncare Research (F); British Contact Lens Association, University of Houston, Visioncare Research (C); Portable Aberrometer, Contrast Sensitivity Chart (P); Johnson & Johnson Vision Care (R). Funding Information: The TFOS DEWS II workshop participants thank Amy Gallant Sullivan (TFOS Executive Director, USA) for raising the funds that made this Workshop possible; Amy and Rose M. Sullivan (TFOS Operations Manager, USA) for their help in the organization of this Workshop; and Stephanie Wong (University of Waterloo, Canada) for her technical assistance. The TFOS DEWS II was supported by unrestricted donations from Alcon, Novartis , Shire , Allergan , Bausch+Lomb , Akorn , CooperVision , Domp{\'e} , Horus Pharma , Lμbris Biopharma , Oculeve , TearLab , Laboratoires Th{\'e}a , SIFI , Sun Pharma , Johnson & Johnson Vision Care , Carl Zeiss Meditec , Quint Health , Scope Ophthalmics and Senju . ",

year = "2017",

month = jul,

doi = "10.1016/j.jtos.2017.05.005",

language = "English",

volume = "15",

pages = "269--275",

journal = "Ocular Surface",

issn = "1542-0124",

publisher = "Ethis Communications, Inc.",

number = "3",

}

TY - JOUR

T1 - TFOS DEWS II Introduction

AU - Nelson, J. Daniel

AU - Craig, Jennifer P.

AU - Akpek, Esen K.

AU - Azar, Dimitri T.

AU - Belmonte, Carlos

AU - Bron, Anthony J.

AU - Clayton, Janine A.

AU - Dogru, Murat

AU - Dua, Harminder S.

AU - Foulks, Gary N.

AU - Gomes, José A.P.

AU - Hammitt, Katherine M.

AU - Holopainen, Juha

AU - Jones, Lyndon

AU - Joo, Choun Ki

AU - Liu, Zuguo

AU - Nichols, Jason J.

AU - Nichols, Kelly K.

AU - Novack, Gary D.

AU - Sangwan, Virender

AU - Stapleton, Fiona

AU - Tomlinson, Alan

AU - Tsubota, Kazuo

AU - Willcox, Mark D.P.

AU - Wolffsohn, James S.

AU - Sullivan, David A.

N1 - Funding Information: J. D. Nelson, Chair: TearSolutions (I, C, R), Santen (F, C), Editor in Chief, Ocular Surface (F). J. P. Craig, Vice Chair: Allergan (Oculeve), Manuka Health NZ (F), E-Swin, CooperVision, Alcon, Optima Pharmaceuticals, OPSM NZ, Akorn, Optimed, Medmont (R); Carl Zeiss Meditec, Eye Institute Auckland (C). D. A. Sullivan, Organizer: Allergan, Cempra, GlaxoSmithKline, Novagali/Santen, TearLab, (F); Singularis (I); M.G. Therapeutics (C); Dompé, Fovea, Laboratoire Théa, Lμbris Sanofi/Novartis, (R). E. Akpek: Allergan (F); Biogen, Seattle Genetics, GSK, Nicox (C). D. Azar: Novartis/Alcon, Google. Chicago Medical Society (F); Novartis, Google, (I); University of Illinois (E); Alcon/Google (C); Novartis/Alcon/Google (R). C. Belmonte: Avizorex Pharma, (F) (I) (C) (P) (R); Coopervision (F). A. J. Bron: Allergan, DiagnosTear, TearLab, Reckitt Benckiser (C); Allergan (R); TearLab (F) (I). J. A. Clayton: National Institutes of Health (E). M. Dogru: Otsuka Pharmaceuticals (F), Santen (F). H. Dua: Novartis (F); GlaxoSmithKline (I); Nicox, Théa, Allergan (C); NuVision (P); Alcon, Allergan, Bausch & Lomb, Nicox, Théa; NuVision (S). G. N. Foulks: TearLab (I); Eleven Biotherapeutics, Inc; Healios, Inc; Insite Pharmaceuticals, Inc; Kala, Inc; Lexitas, Inc; Parion, Inc; R-Tech Ueno, Inc; and Shire Pharmaceuticals, Inc. (C). J. A. P. Gomes: Allergan, Alcon, Bausch & Lomb/Valeant, Genon, Pfizer, MSD, Mundipharma (F); Allergan, Bausch & Lomb/Valeant (C). K. M. Hammitt: N. L. Jones: Advanced Vision Research, Alcon, Allergan, Contamac, CooperVision, Essilor, Inflamax, Johnson & Johnson Vision Care, Ocular Dynamics, Oculus, Safilens, TearLab, TearScience (F); Alcon, CooperVision, Johnson & Johnson Vision Care (C) (R). C-K. Joo: N. Z. Liu: Reilin Co. (C); Santen, Reilin, Alcon (R). J. J. Nichols: Johnson and Johnson Vision Care (F); Bruder Healthcare Company (F); Alcon (spouse), Allergan (spouse), Eleven Biotherapeutics (spouse), Kala, Oculus (spouse), Sarcode/Shire (spouse), TearScience (spouse), (F); Alcon (Spouse), Allergan (Spouse), Bausch & Lomb/Valeant (spouse), Eleven Biotherapeutics (spouse), Kala (Spouse), Insite Pharma (spouse), Parion (spouse), Sarcode/Shire (spouse), ScienceBased Health (spouse), Santen (spouse), Tearfilm Innovations (spouse), (C); Shire (R). K. K. Nichols: Allergan, Bruder Healthcare Company (spouse) Eleven Biotherapeutics, Johnson and Johnson Vision Care (spouse), Kala, Oculus, Sarcode/Shire, TearScience (F); Alcon, Allergan, Bausch & Lomb/Valeant, Eleven Biotherapeutics, Kala, Insite Pharma, Parion, Sarcode/Shire, ScienceBased Health, Santen, Tearfilm Innovations (C); Shire (Spouse) (R). G. D. Novack: Aldeyra, Allergan, Allysta, AmorChem, Aurinia Pharm, Auven, Bausch+ Lomb, CapaBio, Clementia Pharma, Eleven Biotherapeutics, I.com Medical, Kala Pharma, Lexitas Pharma, Lubris, MG Therapeutics, Oculeve, Oyster Point Pharma, Panoptica, Inc., Parion Sciences, Inc., Proteris Biotech, Inc., Senju Pharmaceutical Co., Ltd, Shire Pharmaceuticals, Inc., Sun Pharma, Sylentis, Theravance (C). V. Sangwan: N. F. Stapleton: Alcon Laboratories, Allergan, CooperVision, Johnson & Johnson Vision Care, Stiltec (F); Nidek (C). K. Tsubota: Dai Nippon Insatsu, Echo Denki, JIN Co, Ltd., Kowa Co. Ltd., MediProduct, Inc., Molecular Physiology Chemistry Laboratory, Inc., Novartis Pharma K.K., Oryza Oil & Fat Chemical Co., Ltd., Santen Pharmaceutical Co., Ltd., Toshiba Materials Co., Ltd., WAKASA SEIKATSU Corp. (F); QOV, Inc., Tear Solutions, Tissue Tech Inc., Tsubota Laboratory, Inc. (I); Laboratoires Théa, Novaliq GmbH, SIFI, SpA (C); Functional Visual Acuity Meter, Moisture Glasses, Menisometry Strips, Vitamin D Ointment (P); AMO Japan K.K.; NIDEK Co. Ltd., Otsuka Pharmaceutical Co Ltd; Santen Pharmaceutical Co., Ltd. (R); Ocular Surface Research & Education Foundation (Board of Directors); Qualitas Inc., (Advisory Board); TearSolutions (Advisory Board); Yolia Health (Advisory Board); Metro Biotech (Advisory Board); Nobel Institute of Medical Science; (Spouse's company) (S). M. D. P. Willcox: Alcon Laboratories, Allergan, CooperVision, Johnson & Johnson Vision Care, Ophtecs (F); Allergan, Minomic International Pty., Ophtecs, Warm Contacts (C); Allergan, Ophtecs (R); Minomic International Pty., Ophtecs (S). J. S. Wolffsohn: Alcon, Bausch + Lomb, CooperVision, Eaglet Eye, European Union, Eyebag, EMPharma, EyeDocs, Innovate UK, Johnson & Johnson, Medmont, Théa, Optimec, Visioncare Research (F); British Contact Lens Association, University of Houston, Visioncare Research (C); Portable Aberrometer, Contrast Sensitivity Chart (P); Johnson & Johnson Vision Care (R). Funding Information: The TFOS DEWS II workshop participants thank Amy Gallant Sullivan (TFOS Executive Director, USA) for raising the funds that made this Workshop possible; Amy and Rose M. Sullivan (TFOS Operations Manager, USA) for their help in the organization of this Workshop; and Stephanie Wong (University of Waterloo, Canada) for her technical assistance. The TFOS DEWS II was supported by unrestricted donations from Alcon, Novartis , Shire , Allergan , Bausch+Lomb , Akorn , CooperVision , Dompé , Horus Pharma , Lμbris Biopharma , Oculeve , TearLab , Laboratoires Théa , SIFI , Sun Pharma , Johnson & Johnson Vision Care , Carl Zeiss Meditec , Quint Health , Scope Ophthalmics and Senju .

PY - 2017/7

Y1 - 2017/7

UR - http://www.scopus.com/inward/record.url?scp=85025432066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025432066&partnerID=8YFLogxK

U2 - 10.1016/j.jtos.2017.05.005

DO - 10.1016/j.jtos.2017.05.005

M3 - Review article

C2 - 28736334

AN - SCOPUS:85025432066

VL - 15

SP - 269

EP - 275

JO - Ocular Surface

JF - Ocular Surface

SN - 1542-0124

IS - 3

ER -

TFOS DEWS II Introduction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this